Bryce A. Kerlin, MD

Bryce A. Kerlin, MD is the Director of the Hemophilia and Bleeding Disorder Program for the Nationwide Children’s Hospital Hemostasis and Thrombosis Center, a member of the Division of Hematology/Oncology/BMT and an Associate Professor of Pediatrics at The Ohio State University College of Medicine. His research interests include the epidemiology and treatment of thrombosis and bleeding disorders as well as the interaction between the coagulation system and innate immunity. He is the principle investigator for a national thromboembolism registry and institutional principle investigator for several other national hemophilia treatment studies.

Gender:

• Male

Languages Spoken:

• English

Research Center:

• Center for Clinical and Translational Research

Research Funding*:

• Patient and Family Support Group for Hemophilia Clinic, Hemophilia Foundation of Michigan/Cascade Hemophilia Consortium

Medical School

• Medical College of Wisconsin

Post Doctoral

• Blood Research Institute: The Blood Center of Southeastern Wisconsin

Fellowship

• Medical College of Wisconsin and Children’s Hospital of Wisconsin

Undergraduate

• Purdue University

Medical School

• Medical College of Wisconsin
  Date Completed: 05/18/1996

Internship

• Phoenix Children's Hospital
  Date Completed: 06/30/1997

Residency

• Phoenix Children's Hospital
  Date Completed: 06/30/1999

Fellowship

• Medical College of Wisconsin
  Date Completed: 06/30/2002

Department:

• Pediatrics

Section:

• Hematology/Oncology

Speciality:

• Pediatric Hematology Oncology, Certified
  
• Pediatrics
  

Date of Appointment at Children's Hospital:

• 12/31/2004

2005–present

• Director of Hematology, Nationwide Children's Hospital

2004–present

• Tumor Board,  Nationwide Children's Hospital

2004–present

• Pharmacy & Therapeutics, Nationwide Children's Hospital

2004–present

• Director, Nationwide Children's Hospital Hemophilia & Bleeding Disorders Program

2004–present

• Board Member, Ohio Bleeding Disorders Council
  

2004–2004

• Pharmacy & Therapeutics Committee, Children's Hospital of San Diego

2002–2004

• Medical Director, Hemophilia Association of San Diego County

2002–2004

• Transfusion Medicine Committee, Children's Hospital of San Diego

2002–2004

• Cancer Committee, Children's Hospital of San Diego

2002–2004

• Director, San Diego Regional Pediatric Hemophilia Program

2002–2004

• Tumor Board; Children's Hospital of San Diego

1999–2002

• Tumor Board; Children's Hospital of Wisconsin

1998–1999

• Director, Resident as Teacher Program; Phoenix Children’s Hospital/Maricopa Medical Center Pediatric Residency Program

1998–1999

• Chairman, House Staff Social Committee; Phoenix Children’s Hospital/Maricopa Medical Center Pediatric Residency Program

• KERLIN BA. 2011. Pulmonary Morbidity of Catheter-Related Pediatric Venous Thromboembolism: Old Problem, New Worry.  Critical Care Medicine. Edited by Joseph E. Parrillo, MD, FCCM. (IF: 6.373) (Formally Accepted)
• Karsies TJ, Nicol KK, Galantowicz ME, Stephens JA, KERLIN BA. 2010. Thrombotic Risk of Recombinant Factor Seven in Pediatric Cardiac Surgery: A Single Institution Experience.  Annals of Thoracic Surgery. Vol. 89, no. 2. (February): 570-577. (IF: 2.689)
• Sladky JL, Klima J, Grooms L, KERLIN BA, O?Brien SH. 2010. The PFA-100 does not Predict Delta-Granule Platelet Storage Pool Deficiencies. [Abstract]. Blood. Vol. 116: 2518. (IF: 10.555) [Refereed] (Published)
• Sharathkumar A, Hardesty B, Greist A, Salter J, KERLIN B, Heiman M, Sulkin M, Shapiro A. 2009. Variability in Bleeding Phenotype in Amish Carriers of Hemophilia B with the C31008T Mutation.  Haemophilia. Vol. 15: 91-100. (IF: 1.947)
• KERLIN BA. 2009. Thrombolysis for Pediatric Venous Thromboembolism: Is it Time for a Trial?.  Pediatric Blood & Cancer. Vol. 53. Edited by Arceci R: 920-921. (IF: 2.164)
• Hyatt SA, Wang W, KERLIN BA, O'Brien S. 2009. Applying Diagnostic Criteria for Type 1 von Willebrand Disease to a Pediatric Population.  Pediatric Blood & Cancer. Vol. 52: 102-107. (IF: 2.164)
• KERLIN BA, Blatt NB, Fuh B, Zhao S, Lehman A, Blanchong C, Mahan JD, Smoyer WE. 2009. Epidemiology and Risk Factors for Thromboembolic Complications of Childhood Nephrotic Syndrome: A Midwest Pediatric Nephrology Consortuim (MWPNC) Study.  The Journal of Pediatrics. Vol. 155: 105-110. (IF: 4.017)
• KERLIN BA. 2009. Screening for Anemia. In Textbook of Pediatric Care. 1st ed. Edited by McInerny TK, Adam HM, Campbell D, Kamat DK, Kelleher KJ. Elk Grove Village, IL, USA: American Academy of Pediatrics. 342-343.
• KERLIN BA, Palumbo JS, Nicol KK, Bove KE, Ranalli MA. 2009. Tissue Factor Expression by Common Pediatric Malignant Tumors: A Pilot Feasibility Study [Abstract]. Haemophilia. Vol. 15: 627-627. [Refereed] (Published)
• Mast KJ, Nunes ME, Ruymann FB, KERLIN BA. 2009. Desmopressin Responsiveness in Children with Ehlers-Danlos Syndrome Associated Bleeding Symptoms.  British Journal of Haematology. Vol. 144: 230-233. (IF: 4.490)
• Klopfenstein KJ, Clayton J, Rosselet R, KERLIN B, Termuhlen A, Gross T. 2009. Prevalence of Abnormal Bone Density of Pediatric Patients Prior to Blood or Marrow Transplant.  Pediatric Blood & Cancer. Vol. 53: 675-677. (IF: 2.164)
• Rose MJ, Nicol KK, Skeens MA, Gross TG, KERLIN BA. 2008. Congenital Amegakaryocytic Thrombocytopenia: the Diagnostic Importance of Combining Pathology with Molecular Genetics.  Pediatric Blood & Cancer. Vol. 50: 1263-1265. (IF: 2.164)
• Lo W, Zamel K, Ponnappa K, Allen A, Chisolm D, Tang M, KERLIN B, Yeates KO. 2008. The Cost of Pediatric Stroke Care and Rehabilitation.  Stroke. Vol. 39: 161-165. (IF: 6.296)
• KERLIN BA, Cataland S, Varga E, Kraut E, Wurster M. 2008. Common Clinical Variables Predict Warfarin Maintenance Dose and Therapeutic Resistance [Abstract]. Journal of Thrombosis and Thrombolysis. Vol. 25: 101-101. [Refereed] (Published)
• Varga EA, KERLIN BA, Wurster MW. 2008. Social and Ethical Controversies in Thrombophilia Testing and Updates on Genetic Risk Factors for Venous Thromboembolism. Review of Thrombophilia Controversies. Seminars in Thrombosis and Hemostasis. Vol. 34: 549-561. (3.202) [Editor Reviewed] (Published)
• Lo WD, Allen A, Ponnappa K, Zamel K, KERLIN B, Yeates KO. 2007. The Cost of Pediatric Stroke Care Increases with Infarct Volume, Neurological, and Psychsocial Impairment [Abstract]. Stroke. Vol. 38: 581-581. [Refereed] (Published)
• Hyatt SA, Wang W, KERLIN BA, O?Brien SH. 2007. Applying Diagnostic Criteria for Type 1 von Willebrand Disease to a Pediatric Population [Abstract]. Blood. Vol. 118: 636a-636a. [Refereed] (Published)
• Fuh B, KERLIN B, Blanchong C, Blatt N, Zhoa S, Thornton J, Monda K, Smoyer W, Mahan J. 2007. Incidence and Risk Factors of Deep Venous Thrombosis in Children with Nephrotic Syndrome [Abstract]. E-PAS2007. Vol. 61: 5873.20 http://www.abstracts2view.com/pasall/. [Refereed] (Published)
• Mast KJ, Biega C, Lupia C, Grooms L, Ruymann FB, KERLIN BA. 2007. Desmopressin (DDAVP) Response in Patients with Ehlers-Danlos Syndrome [Abstract]. Pediatric Blood & Cancer. Vol. 48: 631-631. [Refereed] (Published)
• Davis RL, Mosesson MW, KERLIN BA, Canner JA, Ruymann FB, Brennan SO. 2007. Fibrinogen Columbus: a Novel gamma Gly200Val Mutation Causing Hypofibrinogenemia in a Family with Associated Thrombophilia.  Haematologica. Vol. 92: 1151-1152. (IF: 5.516)
• Karsies T, McCormack J, Galantowicz M, Nicol K, KERLIN B. 2007. Recombinant Activated Factor VII and Thrombosis in Pediatric Patients after Surgery for Congenital Heart Disease [Abstract]. Critical Care Medicine. Vol. 35, no. 12 Supplement: A197-A197. [Refereed] (Published)
• Rose MJ, Nicol KK Gross TG, KERLIN BA. 2006. Unusual Bone Marrow Findings in a Patient with Congenital Amegakaryocytic Thrombocytopenia [Abstract]. Blood. Vol. 108: 330a-330a. [Refereed] (Published)
• Savelli SL, KERLIN BA, Springer MA, Monda K, Thornton J, Blanchong CA. 2006. Recommendations for Screening for Thrombophilic Tendencies in Teenage Females Prior to Contraceptive Initiation. Review of Thrombophilia and Contraception. Journal of Pediatric and Adolescent Gynecology. Vol. 19: 313-316. (0.758) [Editor Reviewed] (Published)
• Savelli SL, Kerlin BA, Springer MA, Monda K, Thornton J, Blanchong CA: Recommendations for Screening for Thrombophilic Tendencies in Teenage Females Prior to Contraceptive Initiation.  Journal of Pediatric and Adolescent Gynecology 19:313-6, 2006. PubMed ID: 16873040
• Nicol K, Swedan N, Moder P, Kahwash S, Rose M, KERLIN B. 2006. Hemolytic Anemia in a 5-Year-Old Child.  LabMedicine. Vol. 37: 746-748. (IF: 0.197)
• KERLIN B, Moder P, McGlumphy K, Nicol K. 2005. Risks of Thrombotic Events in Cardiac Patients Receiving Activated Factor VII at a Children's Hospital [Abstract]. Transfusion. Vol. 45: 111A-111A. [Refereed] (Published)
• Loh KC, Willert J, Meltzer H, Roberts W, KERLIN B, Kadota R, Levy M, White G, Geddis A, Schiff D, Martin L, Yu A, Kung F, Spear MA. 2005. Temozolomide and Radiation for Aggressive Pediatric Central Nervous System Malignancies.  Journal of Pediatric Hematology/Oncology. Vol. 27, no. 5: 254-258. (IF: 1.278)
• KERLIN BA, Cooley BC, Isermann BH Hernandez I, Sood R, Zogg M, Hendrickson SB, Mosesson MW, Lord S, Weiler H. 2004. Cause-Effect Relation between Hyperfibrinogenemia and Vascular Disease.  Blood. Vol. 103, no. 5: 1728-1734. (IF: 10.896)
• Weiler H, KERLIN B, Lytle MC. 2004. Factor V Leiden Polymorphism Modifies Sepsis Outcome: Evidence from Animal Studies.  Critical Care Medicine. Vol. 32, no. 5 Supplement: S233-S238. (IF: 6.283)
• Greenbaum LA, KERLIN BA, Van Why S, Punzalan RC, Trost BA, Pan CG, Scott JP. 2003. Concurrent Poststreptococcal Glomerulonephritis and Autoimmune Hemolytic Anemia.  Pediatric Nephrology. Vol. 18, no. 12: 1301-1303. (IF: 1.936)
• KERLIN BA, Yan SB, Isermann BH, Brandt JT, Sood R, Basson BR, Joyce DE, Weiler H, Dhainaut J-F. 2003. Survival Advantage Associated with Heterozygous Factor V Leiden Mutation in Patients with Severe Sepsis and in Mouse Endotoxemia.  Blood. Vol. 102, no. 9: 3085-3092. (IF: 10.896)
• KERLIN BA, Cooley B, Johnson J, Fehrmann S, Zogg M, Weiler H. 2002. The Inflammatory Cytokine Response of Mice Carrying the Factor V Leiden Mutation is Regulated by Increased Production of Activated Protein C [Abstract]. Arteriosclerosis, Thrombosis, and Vascular Biology. Vol. 22: 878a-3-878a-3. [Refereed] (Published)
• KERLIN BA, Cooley B, Lord S, Weiler H. 2002. Consequences of Chronically Elevated Plasma Fibrinogen Levels on Thrombosis in Genetically Hypercoagulable Mice [Abstract]. Arteriosclerosis, Thrombosis, and Vascular Biology. Vol. 22: 878a-41-878a-41. [Refereed] (Published)
• KERLIN BA, Scott JP. 2001. Recombinant Erythropoietin and Corticosteroid Therapy for Delayed Hemolytic Transfusion Reactions in Hemoglobin SS Disease [Abstract]. Journal of Pediatric Hematology/Oncology. Vol. 23, no. 3: A10-A10. [Refereed] (Published)
• Weiler H, Lindner V, KERLIN B, Isermann BH, Hendrickson SB, Cooley BC, Meh DA, Mosesson MW, Shworak NW, Post MJ, Conway EM, Ulfman LH, von Andrian UH, Weitz JI. 2001. Characterization of a Mouse Model for Thrombomodulin Deficiency.  Arteriosclerosis, Thrombosis, and Vascular Biology. Vol. 21, no. 9: 1531-1537. (IF: 7.221)
• Sood R, KERLIN BA, Isermann B, Kalloway SM, Weiler H. 2001. Coagulation Factor Signaling in the Placenta: Presence and Functional Activity of an Integrated Coagulation Receptor System [Abstract]. Blood. Vol. 98, no. 11 part 1: 446a-446a. [Refereed] (Published)
• KERLIN BA, Greenbaum LA, Punzalan RC, Trost BA, Pan CG, Gill JC Sheth KJ, Scott JP. 2000. Concurrent Post-infectious Glomerulonephritis and Anti-I Hemolytic Anemia [Abstract]. Journal of Pediatric Hematology/Oncology. Vol. 22, no. 4: 375-375. [Refereed] (Published)
• KERLIN BA, Weiler H, Lecturer. 2001. Inflammatory Response & The Protein C Pathway. Presented at Clinical Hematology Conference Children?s Hospital of Wisconsin. Milwaukee, WI, USA. (January) [Peer Reviewed]
• Rose MJ, Nicol KK, Gross TG, KERLIN BA, Poster Presenter. 2006. Unusual Bone Marrow Findings in a Patient with Congenital Amegakaryocytic Thrombocytopenia. Presented at American Society of Hematology 48th Annual Meeting. Orlando, FL, USA. (December) http://www.hematology.org/. [Peer Reviewed]
• Blatt N, KERLIN B, Fuh B, Zhao S, Blanchong C, Smoyer WE, Mahan JD, Poster Presenter. 2007. The Epidemiology of Thromboembolism in Children with Nephrotic Syndrome: A MidWest Pediatric Nephrology Consortium (MWPNC) Study. Presented at American Society of Nephrology 40th Annual Meeting and Scientific Exposition. San Francisco, CA, USA. (October) http://www.asn-online.org/education_and_meetings/. [Peer Reviewed]
• KERLIN BA, Presenter. 2008. Thrombosis Data Collection: Lessons Learned from the HTRS TERegistry. Presented at American Thrombosis & Hemostasis Network Data Summit 2008. Chicago, IL, USA. (July) http://www.athn.org/.
• KERLIN B, Moder P, McGlumphy K, & Nicol K, Poster Presenter. 2005. Risks of Thrombotic Events in Cardiac Patients Receiving Activated Factor VII at a Children?s Hosptital. Presented at AABB Annual Meeting and TXPO. Seattle, WA, USA. (October) http://www.aabb.org/Content/Meetings_and_Events/Annual_Meeting_and_TXPO/. [Peer Reviewed]
• KERLIN BA, Lecturer. 2006. Kids and Blood Clots: Blood Clots and Blood Clotting Disorders - Key Issues in Diagnosis, Treatment and Prevention. Presented at Regional Seminar of The National Alliance for Thrombosis and Thrombophilia. Columbus, OH, USA. (May)
• KERLIN BA, Silber, GH, Lecturer. 1998. Hermansky-Pudlak Syndrome. Presented at Pediatric Grand Rounds: Clinical Pathology Conference Phoenix Children?s Hospital. Phoenix, AZ, USA. (March) http://www.phoenixchildrenshospital.com/. [Peer Reviewed]
• KERLIN BA, Cooley B, Johnson J, Fehrmann S, Zogg M, & Weiler H, Presenter. 2002. The Inflammatory Cytokine Response of Mice Carrying the Factor V Leiden Mutation is Regulated by Increased Production of Activated Protein C. Presented at American Heart Association: 3rd Annual Arteriosclerosis, Thrombosis, and Vascular Biology Meeting. Salt Lake City, UT, USA. (April) http://www.americanheart.org/presenter.jhtml?identifier=3057022. [Peer Reviewed]
• KERLIN BA, Presenter. 2006. Hemophilia Sports, Exercise, & Obesity. Presented at Columbus Children?s Hospital?s Hemophilia Treatment Center 1st Annual Infusion Weekend. Deer Creek State Park, OH, USA. (January)
• KERLIN BA, Lecturer. 2007. Pediatric Thrombosis & Thrombophilia. Presented at Grand Rounds Columbus Children's Hospital. Columbus, OH, USA. (May)
• KERLIN BA, Stirlings J, Moderator. 2004. Hemostatic Disorders and Child Abuse. Presented at 18th Annual San Diego International Conference on Child and Family Maltreatment. San Diego, CA, USA. (January) http://www.chadwickcenter.org/conference.htm.
• KERLIN BA, Lecturer. 2003. Disorders of Coagulation in Children. Presented at Pediatric Grand Rounds Rady Children?s Hospital and Health Center. San Diego, CA, USA. (February)
• Biega C, Lupia CH, Grooms LP, Casto L, KERLIN B, Poster Presenter. 2007. Transition from Central Lines to Peripheral Venous Factor Infusions Improved by Participation in Family Retreats and Hemophilia Camps. Presented at National Hemophilia Foundation 59th Annual Meeting. Orlando, FL, USA. (October) http://www.hemophilia.org/NHFWeb/MainPgs/MainNHF.aspx?menuid=0&contentid=1. [Peer Reviewed]
• KERLIN BA, Lecturer. 2004. Evaluation of the Bleeding Child. Presented at Lounge & Learn Columbus Children?s Hospital. Columbus, OH, USA. (September)
• KERLIN BA, Cataland S, Varga E, Kraut E, Wurster M, Poster Presenter. 2007. Common Clinical Variables Predict Warfarin Maintenance Dose and Therapeutic Resistance. Presented at Anticoagulation Forum?s 9th National Conference on Anticoagulant Therapy. Chicago, IL, USA. (May) http://www.acforum.org/index.htm. [Peer Reviewed]
• KERLIN BA, Palumbo JS, Nicol KK, Bove KE, Ranalli MA, Poster Presenter. 2008. Tissue Factor Expression by Common Pediatric Malignant Tumors: A Pilot Feasibility Study. Presented at 2008 Annual Scientific Symposium of the Hemophilia & Thrombosis Research Society. Chicago, IL, USA. (April) http://htrs.org/. [Peer Reviewed]
• KERLIN BA, Presenter. 2006. Hemophilia 101/Basics. Presented at The FAMOHIO 15th Annual Hemophilia Educational Symposium and Annual Meeting. Columbus, OH, USA. (August)
• KERLIN BA, Presenter. 2006. TERegistry. Presented at Hemophilia & Thrombosis Research Society?s Annual Thrombosis Committee Breakfast Meeting. Orlando, FL, USA. (December) http://htrs.org/. [Peer Reviewed]
• Sood R, KERLIN BA, Isermann B, Kalloway SM, & Weiler H. 2001. Coagulation Factor Signaling in the Placenta: Presence and Functional Activity of an Integrated Coagulation Receptor System. Presented at The American Society of Hematology 43rd Annual Meeting. Orlando, FL, USA. (December) http://www.hematology.org/. [Peer Reviewed]
• KERLIN BA, Lecturer. 2007. The Bleeding Child in the Emergency Department. Presented at Pediatric Emergency Medicine Grand Rounds Columbus Children?s Hospital. Columbus, OH, USA. (April)
• Perdue K, Cataland S, Kraut E, Blanchong C, O?Brien S, KERLIN B, Poster Presenter. 2007. HTRS TERegistry: Offering a Better Understanding of ThromboEmbolic Disease. Presented at Hemophilia and Thrombosis Research Society 3rd Annual Meeting. Chicago, IL, USA. (April) http://htrs.org/. [Peer Reviewed]
• KERLIN BA, Presenter. 1999 - 2002. Multiple Comprehensive Oncology and Bone Marrow Transplantation Presentations. Presented at Tumor Board: Medical College of Wisconsin and Children?s Hospital of Wisconsin. Milwaukee, WI, USA. (July - June) [Peer Reviewed]
• KERLIN BA, Greenbaum LA, Punzalan RC, Trost BA, Pan CG, Gill JC, Sheth KJ, Scott JP, Poster Presenter. 2000. Concurrent Post-infectious Glomerulonephritis and Anti-I Hemolytic Anemia. Presented at American Society of Pediatric Hematology/ Oncology 13th Annual Meeting. Minneapolis, MN, USA. (September) http://www.aspho.org/. [Peer Reviewed]
• KERLIN BA, Presenter. 2005. TERegistry. Presented at Hemophilia & Thrombosis Research Society?s Annual Thrombosis Committee Breakfast Meeting. San Diego, CA, USA. (December) http://htrs.org/. [Peer Reviewed]
• Mast KJ, Biega C, Lupia C, Grooms L, Ruymann FB, KERLIN BA, Poster Presenter. 2007. Desmopressin (DDAVP) Response in Patients with Ehlers-Danlos Syndrome. Presented at American Society of Pediatric Hematology/Oncology 20th Annual Meeting. Toronto, Ontario, Canada. (May) http://www.aspho.org/. [Peer Reviewed]
• Fuh B, KERLIN B, Blanchong C, Blatt N, Zhoa S, Thornton J, Monda K, Smoyer W, Mahan J, Poster Presenter. 2007. Incidence and Risk Factors of Deep Venous Thrombosis in Children with Nephrotic Syndrome. Presented at Pediatric Academic Societies? 2007 Annual Meeting. Toronto, Ontario, Canada. (May) http://www.aps-spr.org/. [Peer Reviewed]
• Setty BA, O?Brien SH, KERLIN BA, Presenter. 2010. Pediatric Venous Thromboembolism: Redefining Epidemiology. Presented at National Conference on Blood Disorders in Public Health. Atlanta, GA, USA. (March) www.blooddisordersconference.com. [Peer Reviewed]
• KERLIN BA, Lecturer. 2004. Approach to the Bleeding Patient. Presented at Resident Grand Rounds Camp Pendleton Naval Hospital. Camp Pendleton, CA, USA. (March)
• KERLIN BA, Presenter. 2004. Thromboembolism Registry Proposal. Presented at Hemophilia & Thrombosis Research Society?s Annual Thrombosis Committee Breakfast Meeting. San Diego, CA, USA. (December) http://htrs.org/. [Peer Reviewed]
• KERLIN BA, Moderator. 2007. Integration of Thrombosis & Thrombophilia into Hemophilia Treatment Centers. Presented at Joint Ohio Hemophilia Treatment Centers Meeting. Columbus, OH, USA. (June)
• Grooms LP, KERLIN B, Casto L, Biega C, Lupia C, Poster Presenter. 2008. Developing a pediatric diagnostic coagulopathy program ? interpreting referral data. Presented at National Hemophilia Foundation 60th Annual Meeting. Denver, CO, USA. (November) http://www.hemophilia.org/NHFWeb/MainPgs/MainNHF.aspx?menuid=0&contentid=1. [Peer Reviewed]
• Lo WD, Allen A, Ponnappa K, Zamel K, KERLIN B, Chisolm D, Yeates KO, Poster Presenter. 2007. The Cost of Pediatric Stroke Care Increases with Infarct Volume, Neurological, and Psychsocial Impairment. Presented at International Strok Conference. San Francisco, CA, USA. (February) http://strokeconference.americanheart.org/portal/strokeconference/sc/programinformation. [Peer Reviewed]
• Powell KK, Perdue KM, Torres MD, Lockhart S, Blanchong CA, O?Brien SH, KERLIN BA, Poster Presenter. 2008. Anatomic Distribution of Childhood Deep Venous Thrombosis: An Interim Analysis of the HTRS TERegistry. Presented at American Society of Pediatric Hematology/Oncology 21st Annual Meeting. Cincinnati, OH, USA. (May) http://www.aspho.org/. [Peer Reviewed]
• KERLIN BA, Lecturer. 2005. Evaluation of the Bleeding Child. Presented at Grand Rounds Columbus Children?s Hospital. Columbus, OH, USA. (July)
• KERLIN BA, Mahan JD, Smoyer WE, Presenter. 2008. Prospective Study of Thromboembolism and Risk Factors in Pediatric Nephrotic Syndrome. Presented at 2008 Midwest Pediatric Nephrology Consortium Meeting. Columbus, OH, USA. (March) http://mwpnc.org/.
• Hyatt SA, Wang W, KERLIN BA, O?Brien SH, Poster Presenter. 2007. Applying Diagnostic Criteria for Type 1 von Willebrand Disease to a Pediatric Population. Presented at American Society of Hematology 49th Annual Meeting. Atlanta, GA, USA. (December) http://www.hematology.org/. [Peer Reviewed]
• Karsies T, McCormack J, Nicol K, Galantowitz M, KERLIN B, Poster Presenter. 2008. Recombinant Activated Factor VII and Thrombosis in Pediatric Patients after Surgery for Congenital Heart Disease. Presented at Society of Critical Care Medicine?s 37th Critical Care Congress. Honolulu, HI, USA. (February) http://www.sccm.org/Annual_Congress/Pages/default.aspx. [Peer Reviewed]
• KERLIN BA, Lecturer. 2009. Pediatric Thrombosis & Thrombophilia. Presented at Pediatric Grand Rounds - East Carolina University Brody School of Medicine. Greenville, NC, USA. (September) http://www.ecu.edu/med/.
• KERLIN BA, Scott JP, Presenter. 2001. Recombinant Erythropoietin and Corticosteroid Therapy for Delayed Hemolytic Transfusion Reactions in Hemoglobin SS Disease. Presented at 25th Annual Children?s Hospital of Wisconsin Residents and Fellows Research Day. Milwaukee, WI, USA. (April) [Peer Reviewed]
• KERLIN BA, Luchtman-Jones L, Massicotte P, Chair. 2007. Difficult Cases in Pediatric Thrombosis. Presented at American Society of Pediatric Hematology/Oncology 20th Annual Meeting. Toronto, Ontario, Canada. (May) http://www.aspho.org/.
• KERLIN BA, Lecturer. 2007. Pediatric Thrombosis & Thrombophilia. Presented at Pediatric Grand Rounds Southern Ohio Medical Center/Scioto County Medical Society. Portsmouth, OH, USA. (December)
• KERLIN BA, Cooley B, Lord S, & Weiler H, Poster Presenter. 2002. Consequences of Chronically Elevated Plasma Fibrinogen Levels on Thrombosis in Genetically Hypercoagulable Mice. Presented at American Heart Association: 3rd Annual Arteriosclerosis, Thrombosis, and Vascular Biology Meeting. Salt Lake City, UT, USA. (April) http://www.americanheart.org/presenter.jhtml?identifier=3057022. [Peer Reviewed]
• KERLIN BA, Scott JP, Poster Presenter. 2004. Recombinant Erythropoietin and Corticosteroid Therapy for Delayed Hemolytic Transfusion Reactions in Hemoglobin SS Disease. Presented at American Society of Pediatric Hematology/Oncology 14th Annual Meeting and Pediatric Academic Societies Annual Meeting. Baltimore, MD, USA. (April) http://www.aspho.org/. [Peer Reviewed]

• Listed, Best Doctors in America